Development Level

Tbio 6 | 10,625
Tchem 2 | 1,890
Tclin 2 | 602

IMPC Term

abnormal lens morphology 1 | 73
cataract 1 | 26
decreased leukocyte cell numbe... 1 | 54

Disease

Cancer 6 | 2,346
Mammary Neoplasms 6 | 410
psoriasis 6 | 6,685
Adenocarcinoma 5 | 115
Breast cancer 5 | 3,099
Prostatic Neoplasms 5 | 471
interstitial cystitis 5 | 2,299
lung cancer 5 | 4,473
non-small cell lung carcinoma 5 | 413
osteosarcoma 5 | 7,933
ovarian cancer 5 | 8,492
pancreatic cancer 5 | 2,300
Adenoma 4 | 165
Carcinoma 4 | 2,147
Esophageal Neoplasms 4 | 67
Glioma 4 | 66
Liver carcinoma 4 | 217
Lung Neoplasms 4 | 171
Neoplasm Metastasis 4 | 138
Papilloma 4 | 27
Stomach Neoplasms 4 | 282
atypical teratoid / rhabdoid tumor 4 | 4,369
cutaneous lupus erythematosus 4 | 1,056
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
malignant mesothelioma 4 | 3,163
non-small cell lung cancer 4 | 2,798
subependymal giant cell astrocytoma 4 | 2,287
Barrett's esophagus 3 | 185
Bladder Neoplasm 3 | 109
Cholangiocarcinoma 3 | 32
Colonic Neoplasms 3 | 126
Disease Progression 3 | 125
Melanoma 3 | 261
Neoplasm Invasiveness 3 | 127
Neoplastic Cell Transformation 3 | 81
Neuroblastoma 3 | 78
Peripheral Neuropathy 3 | 303
Squamous cell carcinoma of esophagus 3 | 82
Squamous cell carcinoma of the head and neck 3 | 24
Vascular disease 3 | 281
adrenocortical carcinoma 3 | 1,427
diabetes mellitus 3 | 1,663
ductal carcinoma in situ 3 | 1,745
gallbladder neoplasm 3 | 9
glioblastoma 3 | 5,572
hepatocellular carcinoma 3 | 550
invasive ductal carcinoma 3 | 2,950
lung adenocarcinoma 3 | 2,714
medulloblastoma, large-cell 3 | 6,234
nasopharyngeal carcinoma 3 | 1,056
pilocytic astrocytoma 3 | 3,086
pituitary cancer 3 | 1,972
posterior fossa group B ependymoma 3 | 1,530
ulcerative colitis 3 | 2,087
Acute kidney injury 2 | 65
Animal Mammary Neoplasms 2 | 136
Cervix uteri carcinoma in situ 2 | 14
Colorectal Neoplasms 2 | 217
DOID:2627 2 | 14
Diabetes Mellitus, Experimental 2 | 106
Diarrhea 2 | 155
Endometriosis 2 | 535
Esophageal carcinoma 2 | 5
Exanthem 2 | 39
Eye disease 2 | 55
Familial adenomatous polyposis 2 | 33
Giant Cell Glioblastoma 2 | 12
Head and neck squamous cell carcinoma 2 | 12
Kidney cancer 2 | 121
Kidney disease 2 | 397
Li-Fraumeni syndrome 2 | 13
Liver neoplasms 2 | 109
Lymphoid leukemia 2 | 69
Lymphoma, T-Cell, Cutaneous 2 | 21
Mammary Neoplasms, Experimental 2 | 150
Mesothelioma 2 | 40
Neoplasm Recurrence, Local 2 | 23
Neoplastic Syndromes, Hereditary 2 | 48
Neurodegenerative disease 2 | 383
Neutropenia 2 | 78
Pancreatic Neoplasm 2 | 79
Pancreatic carcinoma, familial 2 | 8
Pleomorphic adenoma 2 | 18
Polycystic Ovary Syndrome 2 | 335
Renal Cell Carcinoma 2 | 199
Sezary Syndrome 2 | 26
Skin cancer 2 | 37
Squamous cell carcinoma 2 | 96
Thrombocytopenia 2 | 105
Urinary bladder cancer 2 | 34
adult high grade glioma 2 | 2,148
breast carcinoma 2 | 1,614
gliosarcoma 2 | 19
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
medulloblastoma 2 | 1,524
ovarian neoplasm 2 | 97
pancreatic carcinoma 2 | 567
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
sarcoidosis 2 | 368
spina bifida 2 | 1,064

Tissue

Blood and immune system 10 | 17,995
Cardiovascular System 10 | 17,958
Digestive Tract 10 | 18,473
Endocrine System 10 | 18,512
Female tissues 10 | 18,647
Liver and Pancreas 10 | 18,136
Male tissues 10 | 17,969
Nervous System 10 | 18,561
Respiratory system 10 | 17,484
Skin and soft tissues 10 | 18,115
Urinary Tract 10 | 18,444

Target Family

Non-IDG 5 | 11,969
Enzyme 2 | 4,146
Kinase 2 | 634
Transcription Factor 1 | 1,400

Grant Application

5P50CA058207-16 10 | 10
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Thioredoxin, mitochondrial TXN2 Tbio Non-IDG -2.03892 119.3 242
Receptor tyrosine-protein kinase erbB-2 ERBB2 Tclin Kinase -4.25806 19000.3 3336
D-3-phosphoglycerate dehydrogenase PHGDH Tbio Enzyme -3.14492 1317.4 261
Speedy protein A SPDYA Tbio Non-IDG -1.53565 37.8 132
Cellular tumor antigen p53 TP53 Tchem Transcription Factor -4.71557 51004.8 5255
Pro-epidermal growth factor EGF Tbio Non-IDG -3.74596 4837.7 851
Cytochrome c oxidase subunit 2 MT-CO2 Tchem Enzyme -2.94466 857.2 116
Epidermal growth factor receptor EGFR Tclin Kinase -3.98983 9318.1 4989
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.11585 140.7 401
Tumor suppressor ARF CDKN2A Tbio Non-IDG -3.70375 8561.3 896